Schizophrenia Patients May Now Be Able To Make 'Voices In The Head' Quieter
Scientists from St. Jude Children's Research Hospital said they have found a way to make schizophrenia patients' "voices in the head" be quieter. They studied the molecular mechanisms that disrupt the flow of information within neural circuits that connect brain centers, leading people to have auditory hallucinations.
The Team Identified Small RNAs That Could Be Potentially Targeted To Develop Antipsychotic Drugs
Using mice during the study, the research team mimics 22q11 deletion syndrome, also known as DiGeorge syndrome - a syndrome which makes individuals more likely to develop psychiatric conditions. They were able to identify small RNA sequences, or microRNAs, that could potentially be used in targeting for the development of antipsychotic drugs with minimal side effects.
The specific microRNA is called miR-338-3p, which regulates the manufacture of protein D2 dopamine receptor (Drd2) - a primary target of antipsychotics. The researchers found that as microRNA levels declined, levels of Drd2 increased in the auditory thalamus - a brain region associated with auditory hallucinations.
Author Dr. Stanislav Zakharenko said: "In 2014, we identified the specific circuit in the brain that is targeted by antipsychotic drugs. However, the existing antipsychotics also cause devastating side effects. In this study, we identified the microRNA that is a key player in disruption of that circuit and showed that depletion of the microRNA was necessary and sufficient to inhibit normal functioning of the circuit in the mouse model."
Scientists Found Clue As To Only Adults Tend To "Hear Voices"
Researchers also noted that microRNA levels declined with age in mice, whether or not they suffered from DiGeorge syndrome. "While miR-338-3p levels decline as normal mice age, levels may remain above the threshold necessary to prevent over-expression of the protein and hallucinations. In contrast, the deletion syndrome may leave mice at risk for dropping below that threshold," Zharenko said.
Scientists suggest to study the role of microRNA further to help develop more effective antipsychotic drugs.
Facebook Posts Helps Manage Mental Health Disorders
Cambridge researchers believe Facebook status updates, likes and photos, could help professionals better understand mental health disorders.
ADHD Therapeutics Market Revenue Predicted To Go Up
The therapeutic food market is expected to reach $617.4 million by 2024.
MORE IN ITECHPOST
Starbucks Unicorn Frappucino Is A Total Instagram Bait, Find Out Why
The Starbucks Unicorn Frappuccino, a limited-edition drink was released this week and became a viral trend all over the social media, most especially on Instagram.
'Tokyo Ghoul' Season 3 Delayed By Its Live-Action Movie? Ken Kenaki Returns With Another Identity?
"Tokyo Ghoul" season 3's release is delayed and there are countless speculations as to why it is being pushed back. Reports claim that the show is to give way to "One Punch Man" and "My Hero Acdemia" but new rumors say that it's lack of materials and storyline as well as its live-action movie are causing the delay.
Final Fantasy XV: Patch 1.09 Adds New Features For Regalia
Final Fantasy XV patch 1.09 will add exciting new features for the fans most particularly, the upcoming Regalia update which will bring Tera Battle into the game. Here's everything we know so far.